Isolation of SARS-CoV Memory B Cells
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Institute of Oncology Research, National Institutes of Health, Newron Pharmaceuticals (Italy), Luigi Sacco Hospital
Protocol cited in 46 other protocols
Variable analysis
- Seeding of memory B cells at 10 or 50 cells per well
- Presence of EBV (30% supernatant of B95-8 cells)
- Presence of irradiated allogeneic mononuclear cells (50,000 per well)
- Specific antibody production in culture supernatants
- Antibody purification from culture supernatants by affinity chromatography on protein A columns
- Presence of CpG 2006 (2.5 μg/ml) in the complete medium
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!